🇺🇸▼
Female sterilization has long been a common birth control method in the United States. Data shows that 11.5% of American women aged 15 to 49 use it as their primary method. This number is nearly the same as women who rely on the birth control pill. However, the history of this medical procedure is deeply connected to coercion. This coercion took many forms. It included targeting specific racial groups, invalidating consent, and exerting excessive state control.
As a health economist and a political scientist, we have studied the factors that influence women’s choices about contraception. Our recent study reveals a surprising finding. A policy change in the 1990s, which reduced hospital stays for new mothers, had a greater effect on sterilization rates than a landmark civil rights intervention in the 1970s. This suggests that practical policy changes can influence reproductive choices more than public outrage over historical injustices.
Our study revisited Relf v. Weinberger, a pivotal 1974 civil rights case. This case involved the sterilization of two Black girls, known as the Relf sisters. They were sterilized without valid consent. The sisters’ mother was told they were receiving a birth control shot. Instead, doctors performed tubal ligation surgery. This procedure seals the fallopian tubes to prevent pregnancy permanently.
The Relf sisters were not alone. In the early 1970s, their case highlighted broader patterns in federally funded sterilizations. These patterns included invalid consent and pressure tied to public benefits. The U.S. District Court found strong evidence that minors and people unable to consent had been sterilized with federal funds. The court also found that sterilization was often presented as a requirement to maintain welfare benefits. Consequently, the court ruled that federally funded procedures require informed, uncoerced consent.
We examined how public outrage, litigation, and subsequent reforms reshaped U.S. sterilization trends over the next 50 years. We specifically looked at the introduction of a 30-day waiting period. We also analyzed the rule setting a minimum age of 21 for federally funded sterilizations.
We then compared these effects with another inflection point in reproductive health history. This period began in 1992. It is often called the “drive-through delivery” era. At this time, insurance companies instituted fixed payments to hospitals for each birth. Hospitals received the same payment whether women stayed one night or two nights. This structure encouraged shorter stays.
The practical effect was that more women with uncomplicated births were sent home after just one night. In 1996, the Newborns’ and Mothers’ Health Protection Act was passed. This law aimed to end this era of short stays. However, the shift toward shorter postpartum stays persisted. Hospitals continued to cut costs to manage their budgets.
This shortened hospital stay posed a significant problem for women who wanted sterilization. Tubal ligation is logistically easy to provide immediately after birth. But when insurers pushed for shorter stays, providers had less time to schedule the procedure. As a result, fewer women underwent the surgery. This logistical barrier reduced sterilization rates not through legal prohibition, but through administrative convenience.
We compared U.S. sterilization trends with those in other countries. These countries had similar demographic and healthcare trends. They helped us estimate what U.S. patterns might have looked like if the Relf ruling or payment policy changes had not occurred. We tracked national patterns rather than individual medical decisions.
We asked a simple question: What actually changed sterilization practices over time? Was it the public backlash from the Relf ruling? Or was it the quieter administrative change in how childbirth care was paid for?
Our analysis showed that the Relf case slowed the growth of sterilization but did not reverse the trend. The national rate rose from about 5% in 1970 to 13% in 1975. After a brief pause following the ruling, the rate continued climbing. By 1990, nearly one in four married women aged 15-49 were sterilized. We did not see a meaningful shift in the populations most at risk. Younger Black women in the South continued to be disproportionately affected.
By contrast, the administrative payment reforms of the 1990s were associated with the first national declines in sterilization since the 1960s. This decline occurred because the hospital environment changed. Reduced hospital time made it harder to schedule surgery. This suggests that financial structures drive reproductive outcomes as powerfully as legal protections.
Sterilization is neither inherently good nor bad. It is an effective form of permanent contraception. This nuance matters now more than ever. In 2022, the case of Dobbs v. Jackson Women’s Health changed the legal landscape. The Supreme Court ruled that states can set their own abortion laws. This decision limited abortion access for many Americans.
Since that ruling, colleagues have found increases in permanent contraception. These increases are notable among younger adults and in states with strict abortion bans. Limiting patient choices by not providing adequate birth control options is a problem of coercion built into the healthcare structure.
The issue is often not that patients are forced into care. Often, they are offered a narrowed set of options. A person with diabetes may have access to insulin. But they may only have access to a difficult-to-use device. This is a form of structural coercion. In reproductive care, restricting options is a form of coercion, even when it is less visible. When hospital stays are short, the option of postpartum sterilization becomes less available.
At the same time, many patients report being unable to obtain sterilization when they want it. They face barriers such as Medicaid consent rules, hospital logistics, staffing limits, or insurance timing. The problem goes two ways. Some people are pushed toward permanent contraception by restrictive policies. Others are blocked from obtaining it.
This tension is why sterilization is such an important issue. If rates rise or fall in response to payment incentives, it calls into question whether patient decisions are free choices. This is true for reproductive care broadly but has unique human rights implications when the method is permanent.
Our findings suggest that sterilization trends are highly responsive to policy shifts. They respond not only to public outrage but also to the daily workings of the healthcare system. This raises an uncomfortable question. To what extent do trends reflect what people want? And to what extent do they reflect the choices patients were steered toward by the system’s design?
We must consider how financial incentives shape intimate personal decisions. When the cost of a hospital stay is determined by fixed payments, health outcomes may be secondary to financial goals. This dynamic applies to sterilization as much as it does to abortion. Understanding these hidden forces is essential for ensuring that reproductive choices remain truly voluntary and informed.
The history of sterilization in the United States is a complex mix of legal victories, social injustices, and administrative changes. While the Relf case was crucial for establishing consent, quiet shifts in insurance payments may have altered reproductive health more profoundly. As we navigate a new era of reproductive rights, we must pay attention to these structural factors. We must ensure that the healthcare system supports patient autonomy rather than undermining it through logistical and financial barriers.